Article Correctness Is Author's Responsibility: Leinco Technologies, Inc., and La Jolla Institute for Immunology announce license agreement

La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system announced today that it has signed a licensing agreement with Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates.